Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Leading Femtech Brand INNOVO Appoints New CFO
Today Atlantic Therapeutics, a Galway-based MedTech and Femtech innovator, is pleased to announce the appointment […]
MindMed Announces Transition of CFO
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company […]
Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist
French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]
CND Life Sciences Adds Two Accomplished Pathologists to Leadership Team
CND Life Sciences, Inc. (www.cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and […]
UnityPoint Health Announces New Chief Nursing Officer
UnityPoint Health® is pleased to announce that Dr. D’Andre Carpenter has been selected as Chief […]
David Dimmock, M.D., Joins Creyon Bio as Chief Medical Officer
Creyon Bio, Inc. (“Creyon Bio”), a drug development company engineering RNA-based medicines and their components […]
Clint Carnell Named CEO of InBrace
InBrace, the orthodontic company behind the novel Smartwire® technology, announced today that Clint Carnell will join as […]
Haemonetics Appoints James D'Arecca Chief Financial Officer
Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive […]
Avacta Appoints Dr Christina Coughlin as Non-Executive Director
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and […]
David Thompson Joins OPEN Health as Chief Executive Officer for Evidence & Access
OPEN Health is pleased to announce the appointment of David Thompson, PhD, as Chief Executive Officer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more